EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells

Ilona Krabicová iD, Yousef Khazaei Monfared iD, Fabrizio Caldera iD, Mohammad Mahmoudian, Christopher Hobbs iD, Rosangela Santalucia iD, Silvia Lucia Appleton, Adrián Matencio iD, Parvin Zakeri-Milani, Francesco Trotta

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ilona Krabicová und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Humanities and Education, Technical University of Liberec, 461 17 Liberec, Czech Republic. Hauptthemen laut MEDLINE: Cholesterol, Cyclodextrins, Resveratrol, Drug Delivery Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth and Sports, Czech Republic, Ministry of Education, Youth and Sports of the Czech Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol, the essential building block of cellular membranes, has proven to be a useful tool for increasing the biocompatibility and bioavailability of drug delivery systems in cancer treatment. Resveratrol, a natural polyphenolic compound with promising anticancer properties, faces significant limitations due to its low solubility and bioavailability, hindering its clinical utility. Therefore, in the present study, we aimed to design cholesterol-functionalized cyclodextrin nanosponges (Chol-NSs) with a tunable cholesterol content to optimize resveratrol encapsulation and delivery. Both formulations, free carbonyl diimidazole (CDI) NSs and functionalized Chol-NSs, demonstrated high drug loading and encapsulation efficiency. In vitro experiments revealed that cholesterol incorporation significantly improved the cellular uptake of nanocarriers and potentiated the cytotoxic effects of resveratrol on breast cancer cells. Importantly, both free CDI NSs and functionalized Chol-NSs, even at varying cholesterol percentages, demonstrated a safe profile against both fibroblast and breast cancer cell lines. These results indicate that cholesterol-functionalized nanosponges represent a promising platform for the effective and safe delivery of natural compounds in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolCyclodextrinsResveratrolDrug Delivery SystemsNanostructuresBreast NeoplasmsBiological AvailabilityImidazolesDrug Compounding3T3 CellsMCF-7 CellsHumansAnimalsMiceFemaleAntineoplastic Agents

Stichwörter der Autor:innen

cholesterolcrosslinked polymerdrug deliveryfunctionalizationnanosponge

Substanzen

CholesterolCyclodextrinsResveratrolN,N-carbonyldiimidazoleImidazolesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Humanities and Education, Technical University of Liberec, 461 17 Liberec, Czech Republic.
  • Department of Chemistry, University of Turin, 10125 Turin, Italy.
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • NIS Interdepartmental Centre, 10125 Turin, Italy.
  • Department of Oncology, University of Torino, 10060 Candiolo, Italy.
  • Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.

ORCID-Profile: Ilona Krabicová, Yousef Khazaei Monfared, Fabrizio Caldera, Christopher Hobbs, Rosangela Santalucia, Adrián Matencio

Förderung

  • Ministry of Education, Youth and Sports, Czech Republic
  • Ministry of Education, Youth and Sports of the Czech Republic

Zitieren

APA

Krabicová, I., Khazaei Monfared, Y., Caldera, F., Mahmoudian, M., Hobbs, C., Santalucia, R., Appleton, S. L., Matencio, A., Zakeri-Milani, P., & Trotta, F. (2025). Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031213

Vancouver

Krabicová I, Khazaei Monfared Y, Caldera F, Mahmoudian M, Hobbs C, Santalucia R, et al. Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031213

BibTeX
@article{Krabicov2025,
  author = {Krabicová, Ilona and Khazaei Monfared, Yousef and Caldera, Fabrizio and Mahmoudian, Mohammad and Hobbs, Christopher and Santalucia, Rosangela and Appleton, Silvia Lucia and Matencio, Adrián and Zakeri-Milani, Parvin and Trotta, Francesco},
  title = {Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031213}
}
Kostenlos starten →